bioMmune Technologies Inc  

(Public, CVE:IMU)   Watch this stock  
Find more results for Patrick D. Pearson
0.000 (0.00%)
Feb 8 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.18 - 0.45
Open     -
Vol / Avg. 0.00/17,603.00
Mkt cap 11.20M
P/E     -
Div/yield     -
EPS -0.04
Shares 31.90M
Beta     -
Inst. own     -

Key stats and ratios

Q3 (Aug '15) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -54.83% -64.31%
Return on average equity -57.28% -67.18%
CDP Score - -


1780-400 Burrard St
+1-604-6886775 (Phone)
+1-604-6886995 (Fax)


bioMmune Technologies Inc. is a is a tier two research and development issuer. The Company is engaged in the research and development of products for the treatment of cancers and for improvement of the immune system. The Company's intangible assets include technology rights and patents acquired from third parties.

Officers and directors

Karoly Nikolich Ph.D. Chairman of the Board
Age: 56
Reinhard Gabathuler PhD President, Chief Executive Officer, Director
Judi Dalling Chief Financial Officer, Secretary
Patrick W. Gray Ph.D. Chief Scientific Officer, Director
Age: 54
Jens Biertumpel Director
Terry Pearson Ph.D. Director
Age: 69